About David Buchsbaum
David Buchsbaum is a chief financial officer at ADvantage Therapeutics.
David Buchsbaum first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name David Buchsbaum in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Buchsbaum works with at each company, as listed on that company's latest Form D.
ADvantage Therapeutics, Inc. · Form D/A, Jul 28, 2025
WS
Walter Schmidt
Director
AI
Agustin Fernandez Santana III
Executive officer and director
JM
Jeffrey Madden
Executive officer and director
FM
Frank Mattner
Director